Skip to main content
logo
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.7572
-0.0070 (-0.92%)
At close: Oct 7, 2026, 4:00 PM EDT
0.763101
+0.0059 (0.78%)
After-hours: Oct 7, 2026, 7:59 PM EDT

Milestone Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10720515672169276
Market Cap Growth
-48.35%31.26%117.39%-57.49%-38.80%38.33%
Enterprise Value
781801344795151
Last Close Price
0.762.022.361.673.966.55

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
45.54132.73-71.9133.8318.43
PB Ratio
5.864.9111.894.292.552.46
P/TBV Ratio
5.864.9111.894.292.552.46

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
33.26116.31-47.1918.9010.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
7.791.404.173.090.040.01
Net Debt / Equity Ratio
-1.58-1.14-1.13-0.85-0.94-1.01
Net Debt / EBITDA Ratio
0.370.770.360.231.042.64
Net Debt / FCF Ratio
0.470.960.520.311.183.41
Asset Turnover
0.020.02-0.010.050.11
Quick Ratio
7.877.838.799.3410.7216.92
Current Ratio
8.138.019.1010.1111.7017.55
Return on Equity (ROE)
-35522.62%-229.65%-277.55%-143.61%-65.26%-33.52%
Return on Assets (ROA)
-42.77%-41.09%-34.92%-51.01%-38.36%-19.95%
Return on Capital Employed (ROCE)
-49.20%-62.40%-62.50%-89.80%-87.30%-38.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-78.74%-30.73%-26.56%-83.00%-34.52%-15.50%
FCF Yield
-57.78%-24.05%-18.48%-64.72%-31.18%-12.02%
Buyback Yield / Dilution
-77.94%-34.84%-44.82%-1.19%-1.47%-42.56%
SEC Filings: 10-K · 10-Q